Literature DB >> 23938347

Movement activation and inhibition in Parkinson's disease: a functional imaging study.

Elizabeth A Disbrow1, Karen A Sigvardt, Elizabeth A Franz, Robert S Turner, Kim A Russo, Leighton B Hinkley, Timothy J Herron, Maria I Ventura, Lin Zhang, Norika Malhado-Chang.   

Abstract

BACKGROUND: Parkinson's disease (PD), traditionally considered a movement disorder, has been shown to affect executive function such as the ability to adapt behavior in response to new environmental situations. <br> OBJECTIVE: to identify the impact of PD on neural substrates subserving two specific components of normal movement which we refer to as activation (initiating an un-cued response) and inhibition (suppressing a cued response). <br> METHODS: We used fMRI to measure pre-movement processes associated with activating an un-cued response and inhibiting a cued response plan in 13 PD (ON anti-parkinsonian medications) and 13 control subjects. Subjects were shown a visual arrow cue followed by a matched or mismatched response target that instructed them to respond with a right, left, or bilateral button press. In mismatched trials, an un-cued (new) response was initiated, or the previously cued response was suppressed. <br> RESULTS: We were able to isolate pre-movement responses in dorsolateral prefrontal cortex, specifically in the right hemisphere. During the activation of an un-cued movement, PD subjects showed decreased activity in the putamen and increased cortical activity in bilateral DLPFC, SMA, subcentral gyrus and inferior frontal operculum. During inhibition of a previously cued movement, the PD group showed increased activation in SMA, S1/M1, premotor and superior parietal areas. <br> CONCLUSION: Right DLPFC plays a role in pre-movement processes, and DLPFC activity is abnormal in PD. Decreased specificity of responses was observed in multiple ROI's. The basal ganglia are involved in circuits that coordinate activation and inhibition involved in action selection as well as execution.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23938347      PMCID: PMC4586119          DOI: 10.3233/JPD-130181

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  61 in total

Review 1.  The basal ganglia: a vertebrate solution to the selection problem?

Authors:  P Redgrave; T J Prescott; K Gurney
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

2.  Modeling cognitive control in task-switching.

Authors:  N Meiran
Journal:  Psychol Res       Date:  2000

3.  Evolution of the dynamic properties of the cortex-basal ganglia network after dopaminergic depletion in rats.

Authors:  Cyril Dejean; Agnes Nadjar; Catherine Le Moine; Bernard Bioulac; Christian E Gross; Thomas Boraud
Journal:  Neurobiol Dis       Date:  2012-02-12       Impact factor: 5.996

Review 4.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions.

Authors:  G E Alexander; M D Crutcher; M R DeLong
Journal:  Prog Brain Res       Date:  1990       Impact factor: 2.453

5.  Dopamine dependency of cognitive switching and response repetition effects in Parkinson's patients.

Authors:  Sheryl K Shook; Elizabeth A Franz; Christopher I Higginson; Vicki L Wheelock; Karen A Sigvardt
Journal:  Neuropsychologia       Date:  2005       Impact factor: 3.139

6.  Functional role of the basal ganglia in the planning and execution of actions.

Authors:  Oury Monchi; Michael Petrides; Antonio P Strafella; Keith J Worsley; Julien Doyon
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

7.  Hierarchical rule switching in prefrontal cortex.

Authors:  Wako Yoshida; Hidefumi Funakoshi; Shin Ishii
Journal:  Neuroimage       Date:  2009-12-11       Impact factor: 6.556

8.  Somatotopic organization in the internal segment of the globus pallidus in Parkinson's disease.

Authors:  Kenneth B Baker; John Y K Lee; Gaurav Mavinkurve; Gary S Russo; Benjamin Walter; Mahlon R DeLong; Roy A E Bakay; Jerrold L Vitek
Journal:  Exp Neurol       Date:  2010-01-06       Impact factor: 5.330

9.  Executive "brake failure" following deactivation of human frontal lobe.

Authors:  Christopher D Chambers; Mark A Bellgrove; Mark G Stokes; Tracy R Henderson; Hugh Garavan; Ian H Robertson; Adam P Morris; Jason B Mattingley
Journal:  J Cogn Neurosci       Date:  2006-03       Impact factor: 3.225

10.  Dissociable mechanisms of cognitive control in prefrontal and premotor cortex.

Authors:  Christopher D Chambers; Mark A Bellgrove; Ian C Gould; Therese English; Hugh Garavan; Elizabeth McNaught; Marc Kamke; Jason B Mattingley
Journal:  J Neurophysiol       Date:  2007-10-17       Impact factor: 2.714

View more
  10 in total

1.  Stochastic Rank Aggregation for the Identification of Functional Neuromarkers.

Authors:  Paola Galdi; Michele Fratello; Francesca Trojsi; Antonio Russo; Gioacchino Tedeschi; Roberto Tagliaferri; Fabrizio Esposito
Journal:  Neuroinformatics       Date:  2019-10

2.  Single-subject prediction of response inhibition behavior by event-related potentials.

Authors:  Ann-Kathrin Stock; Florin Popescu; Andres H Neuhaus; Christian Beste
Journal:  J Neurophysiol       Date:  2015-12-16       Impact factor: 2.714

3.  Dysfunctional putamen modulation during bimanual finger-to-thumb movement in patients with Parkinson's disease.

Authors:  Li-Rong Yan; Yi-Bo Wu; Xiao-Hua Zeng; Li-Chen Gao
Journal:  Front Hum Neurosci       Date:  2015-09-30       Impact factor: 3.169

4.  A behavioral task for investigating action discovery, selection and switching: comparison between types of reinforcer.

Authors:  Simon D Fisher; Jason P Gray; Melony J Black; Jennifer R Davies; Jeffery G Bednark; Peter Redgrave; Elizabeth A Franz; Wickliffe C Abraham; John N J Reynolds
Journal:  Front Behav Neurosci       Date:  2014-11-18       Impact factor: 3.558

5.  Quantitative Timed-Up-and-Go Parameters in Relation to Cognitive Parameters and Health-Related Quality of Life in Mild-to-Moderate Parkinson's Disease.

Authors:  Janet M T Van Uem; Stefan Walgaard; Erik Ainsworth; Sandra E Hasmann; Tanja Heger; Susanne Nussbaum; Markus A Hobert; Encarnación M Micó-Amigo; Rob C Van Lummel; Daniela Berg; Walter Maetzler
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

6.  Differential Functional Connectivity Alterations of Two Subdivisions within the Right dlPFC in Parkinson's Disease.

Authors:  Julian Caspers; Christian Mathys; Felix Hoffstaedter; Martin Südmeyer; Edna C Cieslik; Christian Rubbert; Christian J Hartmann; Claudia R Eickhoff; Kathrin Reetz; Christian Grefkes; Jochen Michely; Bernd Turowski; Alfons Schnitzler; Simon B Eickhoff
Journal:  Front Hum Neurosci       Date:  2017-05-30       Impact factor: 3.169

7.  Altered Functional Connectivity of Striatal Subregions in Patients with Multiple Sclerosis.

Authors:  Fangyuan Cui; Li Zhou; Zengjian Wang; Courtney Lang; Joel Park; Zhongjian Tan; Yao Yu; Chunyan Sun; Ying Gao; Jian Kong
Journal:  Front Neurol       Date:  2017-04-24       Impact factor: 4.003

8.  Cortical Activation During Finger Tapping Task Performance in Parkinson's Disease Is Influenced by Priming Conditions: An ALE Meta-Analysis.

Authors:  Jingjing Li; Zheng Liu; Zhongquan Du; Ningning Zhu; Xueqing Qiu; Xia Xu
Journal:  Front Hum Neurosci       Date:  2021-11-30       Impact factor: 3.169

9.  Cortical oscillatory dysfunction in Parkinson disease during movement activation and inhibition.

Authors:  Elizabeth A Disbrow; Nathaniel D Glassy; Elizabeth M Dressler; Kimberley Russo; Elizabeth A Franz; Robert S Turner; Maria I Ventura; Leighton Hinkley; Richard Zweig; Srikantan S Nagarajan; Christina R Ledbetter; Karen A Sigvardt
Journal:  PLoS One       Date:  2022-03-04       Impact factor: 3.240

10.  The effect of 8 weeks of treatment with transcranial pulsed electromagnetic fields on hand tremor and inter-hand coherence in persons with Parkinson's disease.

Authors:  Anne Sofie Bøgh Malling; Bo Mohr Morberg; Lene Wermuth; Ole Gredal; Per Bech; Bente Rona Jensen
Journal:  J Neuroeng Rehabil       Date:  2019-01-31       Impact factor: 4.262

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.